Clik here to view.
Shionogi Inc. and Purdue Pharma L.P. Announce U.S. Availability of Symproic®...
OSAKA, Japan & FLORHAM PARK, N.J. & STAMFORD, Conn. Shionogi Inc. and Purdue Pharma L.P. announced today that Symproic® (naldemedine) 0.2 mg tablets are now available throughout the United...
View ArticleClik here to view.
Ipsen Announces That Phase 3 CELESTIAL Trial of Cabozantinib Meets Primary...
PARIS Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) and its partner Exelixis (NASDAQ: EXEL) today announced that its global phase 3 CELESTIAL trial met its primary endpoint of overall survival...
View ArticleClik here to view.
Anika Announces Regulatory Approval for MONOVISC® in Australia for the...
BEDFORD, Mass. Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology,...
View ArticleClik here to view.
Takeda and HemoShear Therapeutics Enter into Exclusive Drug Discovery...
OSAKA, Japan & CHARLOTTESVILLE, Va. Takeda Pharmaceutical Company Limited (TSE: 4502) and HemoShear Therapeutics, LLC, a privately held biotechnology company, today announced a partnership to...
View ArticleClik here to view.
Spectrum Pharmaceuticals Highlights Poziotinib Data in Non-Small-Cell Lung...
HENDERSON, Nev. Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and...
View ArticleClik here to view.
Shinkowa Pharmaceutical Co., Ltd., Distributor of the World’s First...
TOKYO Shinkowa Pharmaceutical Co., Ltd. (Chuo-ward, Tokyo; CEO, Megumi Tanaka) sells the first ever original supplements and cosmetics containing β-nicotinamide mononucleotide (NMN) under the...
View ArticleClik here to view.
Second Sight Announces Appointments of Frank Vandeputte as Vice President and...
SYLMAR, Calif. Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics that provide useful...
View ArticleClik here to view.
Median Technologies Appoints Vivian Wang as General Manager, China and...
SOPHIA ANTIPOLIS, France Regulatory News: Median Technologies (Paris:ALMDT), The Imaging Phenomics Company® today announces the appointment of Vivian Wang as General Manager, China and the...
View ArticleClik here to view.
New Data Demonstrate VTI’s Multifocal Contact Lenses Effective in Reducing...
ATLANTA, Ga. Visioneering Technologies, Inc. (ASX:VTI) today announced the positive results of a new retrospective case series analysis on the impact of its NaturalVue® Multifocal 1 Day Contact...
View ArticleClik here to view.
Breakthrough Medical and Pharmaceutical Funding Awarded to Consortium That...
MELBOURNE, Australia Regenerative skin company Avita Medical is delighted to be part of Accelerating Australia, a consortium that will inject up to $2 million into a breakthrough innovation project...
View ArticleClik here to view.
Zebra Medical Vision要让人人都能容易地取得更加经济实惠的人工智能医疗照护
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 纽约 深度学习影像分析的领导企业Zebra Medical...
View ArticleClik here to view.
Astellas Reports First Half FY2017 Financial Results, Revises Fiscal Year...
TOKYO Astellas Pharma Inc. (TOKYO:4503) (President and CEO: Yoshihiko Hatanaka, “Astellas”) today announced the financial results for the first six months of fiscal year 2017, ending March 31, 2018...
View ArticleClik here to view.
グラミネックス、臨床研究の論文発表を受けてIDIPharmaとの提携を拡大
米ミシガン州サギノー （ビジネスワイヤ） — 溶剤不使用グラミネックス花粉エキスを生産するグラミネックス（Graminex®...
View ArticleClik here to view.
GRAMINEX L.L.C.在临床研究发表后扩大与IDIPharma的伙伴关系
密歇根州萨基诺 (美国商业资讯) — 无溶剂Graminex® Flower Pollen Extract™的生产商Graminex® LLC欣然宣布扩大与IDIPharma的伙伴关系。支持Graminex® Flower Pollen Extract™用于前列腺疼痛及慢性盆腔疼痛(CPP)的多项临床研究完成并发表后，IDIPharma与Graminex®一致同意扩大Graminex®...
View ArticleClik here to view.
Cyrano Announces China Partnership and Associated Financing
WASHINGTON Cyrano Therapeutics, Inc., the leader in therapeutic solutions for taste and smell disorders, today announced the establishment of a formal partnership with Shanghai Newsummit Biopharma...
View ArticleClik here to view.
Median Technologies Adds MediScan® To Its Product Portfolio
SOPHIA ANTIPOLIS, France Regulatory News: This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171031006142/en/ Median Technologies...
View ArticleClik here to view.
MedAdvisor to Expand into Hospitals as EBOS Invests $9.5M at $0.0575 Per Share
MELBOURNE, Australia MedAdvisor (ASX:MDR), Australia’s leading digital medication management company, announces a $9.5 million strategic investment by one of Australasia’s leading healthcare...
View ArticleClik here to view.
Takeda Reports First Half FY2017 Results
OSAKA, Japan Takeda Pharmaceutical Company Limited (TOKYO:4502): Underlying Revenue growth of 6.7% led by Takeda’s Growth Drivers Underlying Revenue grew +6.7% with solid performances across all...
View ArticleClik here to view.
武田薬品：2017年度上期（4-9月期）の連結業績について
大阪 （ビジネスワイヤ） — 武田薬品工業株式会社 （東証：4502）： 実質的な売上収益は＋6.7％の増収、タケダの成長ドライバーが牽引...
View ArticleClik here to view.
Kansai Paint Announces Its Exhibit at MEDICA2017, the World’s Largest Medical...
OSAKA, Japan Kansai Paint Co., Ltd. (Head office: Osaka, President: Hiroshi Ishino) will exhibit at “MEDICA 2017″ Dusseldorf, Germany from Monday, November 13 to Thursday, November 16. “MEDICA” is...
View Article